EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Plasma renin activity as a marker for predicting the antihypertensive effect of switching to sacubitril/valsartan in treated hypertensive patients: Usefulness in daily clinical practice

Takeshi Horio iD, Yoshio Iwashima iD, Minoru Yoshiyama, Daiju Fukuda, Tatemitsu Rai, Kohei Fujimoto

The Journal of Clinical Hypertension · 2024

DOI: 10.1111/jch.14900 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Hypertension, 2024. Verfasst von Takeshi Horio und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Ishikiriseiki Hospital, Higashiosaka, Japan. Hauptthemen laut MEDLINE: Valsartan, Biphenyl Compounds, Aminobutyrates, Hypertension. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The authors investigated the antihypertensive effect of sacubitril/valsartan (Sac/Val) when switching from other drugs and assessed whether brain natriuretic peptide (BNP) or plasma renin activity (PRA) before drug switching was a predictor of blood pressure lowering after switching to Sac/Val. In 92 patients with treated hypertension, clinic blood pressure, plasma BNP, and PRA were examined before and after switching to Sac/Val. Clinic systolic and diastolic blood pressures significantly decreased after drug switching to Sac/Val ( p < .0001, respectively). The level before drug switching of BNP had no correlation with the change in systolic blood pressure (Δ‐SBP) before and after switching to Sac/Val, but that of PRA was significantly correlated with Δ‐SBP ( r = .3807, p = .0002). A multiple regression analysis revealed that PRA before drug switching was an independent determinant of Δ‐SBP. Our findings suggest that low PRA may become a useful marker to predict the antihypertensive effect of switching to Sac/Val in treated hypertensive patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ValsartanBiphenyl CompoundsAminobutyratesHypertensionDrug CombinationsReninBiomarkersBlood PressureTetrazolesNatriuretic Peptide, BrainAntihypertensive AgentsAngiotensin Receptor AntagonistsHumansMaleFemaleAgedMiddle AgedDrug SubstitutionTreatment Outcome

Stichwörter der Autor:innen

angiotensin receptor–neprilysin inhibitorblood pressure loweringbrain natriuretic peptideplasma renin activity

Substanzen

ValsartanBiphenyl CompoundsAminobutyratesDrug Combinationssacubitril and valsartan sodium hydrate drug combinationReninBiomarkersTetrazolesNatriuretic Peptide, BrainAntihypertensive Agents

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine, Ishikiriseiki Hospital, Higashiosaka, Japan.
  • Department of Internal Medicine, Kansai Medical University Kori Hospital, Neyagawa, Japan.
  • Department of Nephrology and Hypertension, Dokkyo Medical University, Mibu, Japan.
  • Department of Internal Medicine, Daito Central Hospital, Daito, Japan.
  • Department of Cardiovascular Medicine, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.

ORCID-Profile: Takeshi Horio, Yoshio Iwashima

Zitieren

APA

Horio, T., Iwashima, Y., Yoshiyama, M., Fukuda, D., Rai, T., & Fujimoto, K. (2024). Plasma renin activity as a marker for predicting the antihypertensive effect of switching to sacubitril/valsartan in treated hypertensive patients: Usefulness in daily clinical practice. The Journal of Clinical Hypertension. https://doi.org/10.1111/jch.14900

Vancouver

Horio T, Iwashima Y, Yoshiyama M, Fukuda D, Rai T, Fujimoto K. Plasma renin activity as a marker for predicting the antihypertensive effect of switching to sacubitril/valsartan in treated hypertensive patients: Usefulness in daily clinical practice. The Journal of Clinical Hypertension. 2024. doi:10.1111/jch.14900

BibTeX
@article{Horio2024,
  author = {Horio, Takeshi and Iwashima, Yoshio and Yoshiyama, Minoru and Fukuda, Daiju and Rai, Tatemitsu and Fujimoto, Kohei},
  title = {Plasma renin activity as a marker for predicting the antihypertensive effect of switching to sacubitril/valsartan in treated hypertensive patients: Usefulness in daily clinical practice},
  journal = {The Journal of Clinical Hypertension},
  year = {2024},
  doi = {10.1111/jch.14900}
}
Kostenlos starten →